Clinical commissioning groups (CCGs) are being urged to take “careful consideration” when developing FreeStyle Libre funding policies to ensure the technology is made available to people who will benefit.
A letter written by Dr Partha Kar, the associate national clinical director for diabetes and NHS England consultant in diabetes medicine, has laid out further clarification on local approaches to the device – made available on the NHS in November last year. To read more, click here.